Clinical Trial Update: Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age

View source ↗

Summary

A completed surveillance study of Respiratory Syncytial Virus (RSV) infections in children under 24 months, sponsored by Gilead Sciences.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Snippet

Sponsor: Gilead Sciences | Conditions: Respiratory Syncytial Virus Infections | Status: COMPLETED